The female condom is a contraceptive method capable of protecting both women and men from sexually transmitted infections, HIV/AIDS and unplanned pregnancies. It can also serve as a barrier method which reduces the risk of being exposed to Human Papilloma Virus (HPV) which, when contracted, can lead to cancer of the uterus.

The female condom has been in Nigeria for as far back as the year 2000. However, the female condom hasn’t garnered much attention from policy & lawmakers, unlike its counterpart, the male condom. As a result of this, the demand and usage of the commodity are almost insignificant.

In order to promote the use of the commodity and its popularity among Nigerians, EVA in partnership with Association for Family and Reproductive Health (ARFH) is implementing a 12-month Female Condom Advocacy Project (FCAP). Female Condom Advocacy Project seeks to increase focus and attention by Sexual and Reproductive Health (SRH) and HIV/ AIDS policy makers, program planners and implementers in Nigeria on the female condom. While some efforts have been made to increase awareness, access, and availability of female condoms, when compared to male condoms the female is seen to receive less attention.

The FCAP is funded by Rutgers WPF and the government of Netherlands. The advocacy project is being carried out to complement the programming phase of the Universal Access to Female Condom (UAFC) which was initiated in 2009 and is still running. Other collaborating partners on the FCAP include Society for Family Health (SFH), UNFPA, and Oxfam Novib.